BioSpace News Archive

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2022 financial results and provided a corporate update.

On February 16, 2023, Enochian BioSciences Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended December 31, 2022.

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry, with focus on the bio-pharmaceutical and cell and gene therapy markets, today announced financial results for the three months and year ended December 31, 2022.

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results for the fourth quarter and the full year ending December 2022.

Nevro Corp. today announced that Nevro will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Call Series on Friday, March 24, 2023 at 2:00 pm Eastern Time.

Guardant Health, Inc. today reported financial results for the quarter and full year ended December 31, 2022.

AbCellera (Nasdaq: ABCL) today announced that it will present at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Olatec Therapeutics LLC (“ Olatec ” or the “ Company ”), a leader in developing NLRP3 inhibitors, announced the completion of the Company’s $40 million Series A round financing, the final closing of which was led by Sanders Morris Harris (“ SMH ”).

Sera Prognostics Inc. today announced that the company will present at the upcoming Cowen Health Care Conference March 6-8, 2023 in Boston.

Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.